Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRINCIPLE: Nicorandil for CIN Prevention
NCT01103336Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Mar 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicorandil in contrast-induced nephropathy (CIN), sponsored by Yonsei University. Started Mar 2010; status: completed.
02
Drugs
nicorandil
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01103336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103336.